Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany; Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Tübingen, Germany.
Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Tübingen, Germany; Section of Experimental Radiology, University Hospital Tübingen, Tübingen, Germany.
Cell Metab. 2017 Aug 1;26(2):292-300. doi: 10.1016/j.cmet.2017.07.008.
A BMI in the normal range associates with a decreased risk of cardiometabolic disease and all-cause mortality. However, not all subjects in this BMI range have this low risk. Compared to people who are of normal weight and metabolically healthy, subjects who are of normal weight but metabolically unhealthy (∼20% of the normal weight adult population) have a greater than 3-fold higher risk of all-cause mortality and/or cardiovascular events. Here we address to what extent major risk phenotypes determine metabolic health in lean compared to overweight and obese people and provide support for the existence of a lipodystrophy-like phenotype in the general population. Furthermore, we highlight the molecular mechanisms that induce this phenotype. Finally, we propose strategies as to how this knowledge could be implemented in the prevention and treatment of cardiometabolic diseases in different stages of adiposity in routine clinical practice.
体重指数(BMI)在正常范围内与心血管代谢疾病和全因死亡率降低相关。然而,并非所有处于这一体重指数范围内的个体都具有这种低风险。与体重正常且代谢健康的人群相比,体重正常但代谢不健康的个体(约占正常体重成年人群的 20%)全因死亡率和/或心血管事件的风险增加了 3 倍以上。在这里,我们探讨了在瘦人中,主要的风险表型在多大程度上决定了代谢健康,与超重和肥胖人群相比,并为普遍存在类似于脂肪营养不良的表型提供了依据。此外,我们强调了诱导这种表型的分子机制。最后,我们提出了在常规临床实践中,如何在不同肥胖阶段将这些知识应用于预防和治疗心血管代谢疾病的策略。